None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Korean female participants aged between 40 and 60 with wrinkle on their crow's feet and nasolabial fold; subjects who sign the informed consent of the study; and those who are cooperative and available for follow-up during the study period.
Exclusion criteria
Exclusion criteria: participants who are pregnant, in nursing condition, or planning to become pregnant; participants who are treated with immune-suppressant within one month from the conduct of the study; participants who participated in a previous study without an appropriate intervening period of one month between studies; participants who have sensitive or hypersensitive skin; participants who have damaged skin in or around the test site, which includes sunburn, tattoos, scars, or other disfiguration on the test site; participants who used similar treatment related to the study during the previous three months; participants who had an experience on test site (skin microdermabrasion, Botox and other skin treatment); participants who have chronic disease (diabetes, asthma, or high blood-pressure); participants who have atopic dermatitis; and participants who have any problem, which might interfere with the healing process.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| kin anti-aging parameters, such as skin hydration, elasticity, lightness, dermal density, sagging, wrinkle and eyebag, are evaluated at baseline, 4 weeks and 8 weeks after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of self-questionnaires | — |
Countries
Asia(except Japan)
Contacts
DHC Corporation Primary Research Unit Primary Research Group 1